LY83583

Overview

LY83583 is inhibitor of soluble guanylate cyclase ( sGC ) with the ability to target the cGMP signaling pathway. LY83583 inhibits the kinase activity-related proliferation of tumor cells by inducing the Cdk inhibitor p21 . LY83583 can be used for the study of cancers (colorectal cancer , breast cancer and melanoma) and cardiovascular disease .

Application

Products | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Colorectal Cancer | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Neurological Disease | Products > Research Areas > Cardiovascular Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Guanylate Cyclase

Product Information

• Catalog No.: HY-W013386
• CAS No.: 91300-60-6
• Molecular Formula: C15H10N2O2
• Molecular Weight: 250.26
• Purity: 99.84%
• Storage: 4°C, sealed storage, away from moisture and light * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
• Solubility: ≥ 2.5 mg/mL (9.99 mM); Clear solution
• Availability: In-stock

Source

Original product source